trial · primary record
Rosuvastatin 10mg
Cholesterol; Lipidosis
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Evaluate effect of Liver Fat Percentage (on MRI) on AUC |
| Registry ID | NCT04903223 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:05.353Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04903223
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.